AstraZeneca PLC Annual Financial Report (5764Q)
February 21 2023 - 6:00AM
UK Regulatory
TIDMAZN
RNS Number : 5764Q
AstraZeneca PLC
21 February 2023
21 February 2023 11:00 GMT
Annual Financial Report
AstraZeneca PLC (the Company) announced today the publication of
its Annual Report and Form 20-F Information 2022 (the Annual
Report).
A copy of the Annual Report will be submitted to the National
Storage Mechanism and will shortly be available for inspection at
https://data.fca.org.uk/#/nsm/nationalstoragemechanism .
The Annual Report is also available on the Company's website
www.astrazeneca.com .
The Annual Report will be dispatched to shareholders in due
course.
The Company's Annual General Meeting (AGM) will take place on 27
April 2023. The Notice of AGM and Shareholders' Circular will be
published and distributed to shareholders in due course.
EXPLANATORY NOTE
For the purposes of complying with the Disclosure and
Transparency Rules, the Annual Report being submitted to the
National Storage Mechanism, contains the following regulated
information in unedited form:
- The principal risks and uncertainties facing the Company;
- The Directors' responsibility statement made in respect of the
Financial Statements and Directors' Report contained in the Annual
Report; and
- A statement regarding related party transactions.
AstraZeneca
AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led
biopharmaceutical company that focuses on the discovery,
development, and commercialisation of prescription medicines in
Oncology, Rare Diseases, and BioPharmaceuticals, including
Cardiovascular, Renal & Metabolism, and Respiratory &
Immunology. Based in Cambridge, UK, AstraZeneca operates in over
100 countries and its innovative medicines are used by millions of
patients worldwide. Please visit astrazeneca.com and follow the
Company on Twitter @AstraZeneca .
Contacts
For details on how to contact the Investor Relations Team,
please click here . For Media contacts, click here .
Adrian Kemp
Company Secretary
AstraZeneca PLC
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
ACSPPUQPPUPWUBG
(END) Dow Jones Newswires
February 21, 2023 06:00 ET (11:00 GMT)
Astrazeneca (LSE:AZN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Astrazeneca (LSE:AZN)
Historical Stock Chart
From Apr 2023 to Apr 2024